| Literature DB >> 32325144 |
Myungjin Jung1, Liye Zou2, Jane Jie Yu3, Seungho Ryu1, Zhaowei Kong4, Lin Yang5, Minsoo Kang1, Jingyuan Lin6, Hong Li6, Lee Smith7, Paul D Loprinzi8.
Abstract
OBJECTIVE: This study aimed to examine (1) the independent effects of hypoxia on cognitive function and (2) the effects of exercise on cognition while under hypoxia.Entities:
Keywords: Cognition; Executive function; Exercise; Hypoxia; Memory
Mesh:
Year: 2020 PMID: 32325144 PMCID: PMC7749263 DOI: 10.1016/j.jshs.2020.04.004
Source DB: PubMed Journal: J Sport Health Sci ISSN: 2213-2961 Impact factor: 7.179
Fig. 1Flow chart of literature search.
Extraction table of the evaluated studies.
| Study | Subject characteristics Age (mean ± SD or range) | Study design | Normoxia/Hypoxia protocol | Hypoxia-exercise temporality | Exercise protocol | Cognitive function assessment | Results |
|---|---|---|---|---|---|---|---|
| Ando et al. (2013) | 12 adult males | Within-subject, Pre–post comparison | Performed cognitive tasks under either normoxia (20.9%) or normobaric hypoxia (18%, 15%) | Hypoxia/Normoxia both before and during exercise | 5 min of cycle ergometer exercise at 20% peak VO2max and 10 min of cycle ergometer exercise at 60% peak VO2max/Acute exercise | GNG (Go/No-Go) task | GNG–RT |
| Schega et al. (2013) | 34 retired older adults | Between-subject, | The CG was supplied with a placebo air mixture and the EG was supplied with an IHT (intermittent hypoxia training) | Hypoxia/Normoxia during exercise | A full-body strength-endurance exercise program at 50% of maximum force/Chronic exercise | d2 test: | GZ |
| Kim et al. (2015) | 8 healthy adult males | Within-subject, | In one of the experimental trials (HY, 12.5%), subjects remained resting in a seated position the entire 5 h; in the other experimental trial (HY + EX), subjects rested 2 h, cycled for 1 h, then rested the last 2 h. | Hypoxia/Normoxia both before and during exercise | 1 h of a Lode cycle exercise (workload equivalent to 50% altitude-adjusted VO2max) | Trail Making Test | Main effect EX: N/A |
| Komiyama et al. (2015) | 16 adult males | Within-subject, | Performed cognitive tasks at rest and during exercise under normoxic and hypoxic conditions (15%) | Hypoxia/Normoxia both before and during exercise | 30 min of cycle ergometer exercise until heart rate was 140 beats/min | Spatial DR | Spatial DR–Accuracy |
| Seo (2015) | 16 young healthy men | Within-subject, counterbalanced, | Performed cognitive tasks at rest and during exercise under normoxic and hypoxic conditions (12.5%) | Hypoxia/Normoxia both before and during exercise | Two 15-min bouts of cycle ergometer exercise at 40% and 60% of adjusted VO2max with 15-min recovery period between bouts/Acute exercise | GNG task, RMCPT | GNG–RT |
| Dobashi et al. (2016) | 8 healthy males | Within-subject, | Performed cognitive tasks before, during, and 60 min after exercise under normoxic and hypoxic conditions (14.1%) | Hypoxia/Normoxia both before and during exercise | Four 30-min bouts of cycle ergometer exercise at moderate intensity with a 15-min interval rest between each set | CWST: | Task 1–Number of Achievement |
| Lefferts et al. (2016) | 30 adults | Within-subject, | Performed cognitive tasks during exercise under normoxic and hypoxic conditions (12.5%) | Hypoxia/Normoxia both before and during exercise | 25-min bouts of cycle ergometer exercise at moderate intensity/Acute exercise | Memory recognition, | Main effect EX: N/A |
| Schega et al. (2016) | 33 older adults | Between-subject, | The CG breathed ambient air and the EG was supplied with IHT (10%) | Hypoxia/Normoxia both before and during exercise | 30-min bouts of bicycle ergometer at moderate intensity/Chronic exercise | Stroop test | Color task |
| Bayer et al. (2017) | 34 older adults | Between-subject, | EG received MTP and IHHT (12%); CG received MTP during the IHHT. Both performed cognitive tasks before and after the training. | Hypoxia/Normoxia during exercise | 2 h of MTP | DemTect, CDT | DemTect |
| Bayer et al. (2017) | 34 older adults | Between-subject, | EG received MTP and IHHT (10%–14%), and CG received MTP during the simulation of IHHT. Both performed cognitive tasks before and after the training. | Hypoxia/Normoxia during exercise | 2 h of MTP | DemTect, CDT | DemTect |
| Komiyama et al. (2017) | 13 adult males | Within-subject, | Performed cognitive tasks at rest and during exercise under either normoxic or hypoxic conditions (13%) | Hypoxia/Normoxia both before and during exercise | 20 min of cycle ergometer exercise at moderate intensity/Acute exercise | Spatial DR, | GNG–RT |
| Seo et al. (2017) | 15 healthy women | Within-subject, Counterbalanced, | Performed cognitive tasks at rest and during exercise under either normoxia or hypoxia (12.5%) | Hypoxia/Normoxia both before and during exercise | Two 15-min bouts of cycle ergometer exercise at 40% and 60% VO2max with a 15-min recovery between bouts/Acute exercise | RMCPT | Main effect EX: |
| Stavres et al. (2017) | 18 adults | Within-subject, Counterbalanced, | Performed cognitive tasks at rest and during exercise under normoxic and hypoxic conditions (12.5%) | Hypoxia/Normoxia both before and during exercise | 20 min of cycle ergometer exercise at moderate intensity/Acute exercise | MATH, RMCPT | MATH |
| Limmer et al. (2018) | 80 adults | Between-subject, | Group A: HP + EX ( | Hypoxia/Normoxia during exercise | Group A: mountain climbing | FAIR-2 | FAIR-2 |
| Bayer et al. (2019) | 34 older adults | Between-subject, | EG received MTP and IHHT (10%–14%), and CG received MTP during the simulation of IHHT. Both performed cognitive tasks before and after the training. | Hypoxia/Normoxia during exercise | 30 min of MTP | DemTect, CDT | Main effect EX: N/A |
| Lei et al. (2019)) | 30 healthy inactive women | Within-subject, | Performed cognitive tasks at rest and during exercise under normoxic and hypoxic conditions (12%) | Hypoxia/Normoxia both before and during exercise | 10-min bouts of cycle ergometer exercise at moderate intensity | Interference control task | Interference control task — RT |
| Morrison et al. (2019) | 11 amateur team-sport athletes | Within-subject, | Performed cognitive tasks before and after exercise under normoxic and hypoxic conditions (14.5%) | Hypoxia/Normoxia during exercise | A repeated sprint-running protocol | DET | DET |
| Sun et al. (2019) | 20 inactive adults | Between-subject, | Performed cognitive tasks before and after exercise under normoxia and hypoxia (15.4%) | Hypoxia/Normoxia both before and during exercise | 6 min of cycle ergometer exercise at high intensity | GNG task | GNG–RT |
Abbreviations: CDT = clock-drawing test; CG = control group; CWST = color-word stroop task; DemTect = dementia detection test; DET = detection task; EG = experimental group; EX = exercise; EX × HY = interaction effect between exercise and hypoxia; FAIR-2 = Frankfurt attention inventory-2; GNG = Go/No-Go; GZ = quantitative performance index; HY = hypoxia; IDN = identification task; IHHT = interval hypoxic–hyperoxic training; M = male; MATH = mathematical; MTP = multimodal training programs; N/A = not assessed; NOR = normoxia; OCL = one card learning task; RCT = randomized controlled trial; RMCPT = running memory continuous performance task; performance task; RT = reaction time; SKL = concentration performance index; Spatial DR = spatial delayed response; VO2max = maximum oxygen uptake; W = woman; ZVT = Zahlen Verbindungs test.
Cognitive tasks and cognitive task categories.
| Category | Task |
|---|---|
| Information processing | Color-word stroop task |
| Attention | d2 test (GZ, SKL) |
| Frankfurt attention inventory-2 | |
| Executive function | Go/No-Go task |
| Zahlen Verbindungs test | |
| Trail making test A and B | |
| Flanker task | |
| Mathematical performance | |
| Interference control task | |
| Memory | Spatial delayed response |
| Running memory continuous performance task | |
| Memory recognition | |
| N-back | |
| One cardlearning task | |
| Dementia detection test | |
| Clock-drawing test | |
| Reaction time | Detection task |
| Identificationtask |
Abbreviations: GZ = quantitative performance index; the rate at which participants mark off each d2 and the overall number of marked letters within the d2 test); SKL = concentration performance index (the standardized number of accurate answers minus confusion errors).
Exclusionary criteria table for each of the included studies.
| Study | Exclusionary criteria |
|---|---|
| Ando et al. (2013) | • Participants who were currently engaged in regular training. |
| Schega et al. (2013) | • Subjects who were physically active and did not pass a medical examination by a medical doctor. |
| Kim et al. (2015) | • Participants who had been exposed to normobaric hypoxia or altitudes over 2500 m within previous 2 months. |
| Komiyama et al. (2015) | • Participants who had any history of cardiovascular, cerebrovascular, or respiratory diseases. |
| Seo et al. (2015) | • Subjects who reported presence or history of pulmonary disease, cardiovascular disease, postural orthostatic |
| Dobashi et al. (2016) | • Participants who had any cardiovascular, cerebrovascular, or respiratory diseases. |
| Lefferts et al. (2016) | • Participants who had experienced smoking, hypertension, diabetes mellitus, hyperlipidemia, pulmonary disease, |
| Schega et al. (2016) | • Participants who had stayed in an altitude above 1800 m, as well as those who gave blood donations, in the past 2 months. |
| Bayer et al. (2017) | • Individuals who were not able to move unaided or who had uncontrolled hypertension (systolic BP >180 mmHg), chronic bronchopulmonary diseases, decompensated heart failure (NYHA, III-IV FC), previous intracerebral hemorrhages, or marked cognitive disorders (MMSE < 12 points). |
| Bayer et al. (2017) | • Subjects who were not able to walk without any staff assistance or suffered from severe dementia with a score of |
| Komiyama et al. (2017) | • Participants who had any history of cardiovascular, cerebrovascular, or respiratory disease. |
| Seo et al. (2017) | • Subjects who not were physically active and had any history of pulmonary disease, cardiovascular disease, postural |
| Stavres et al. (2017) | • Subjects who had any history of any cardiac, metabolic, or respiratory disease; any musculoskeletal issues |
| Limmer et al. (2018) | • Subjects who had previous experience with the Frankfurt attention inventory-2 (FAIR-2) test, altitude sojourns above 2000 m in the 4 weeks prior to the investigation, neurological disease, psychiatric illness, learning |
| Bayer et al. (2019) | • Patients of the Geriatric Day Clinic who did not suffer from any diseases. |
| Lei et al. (2019) | • Subjects who had not lived at an altitude below 1300 m. |
| Morrison et al. (2019) | • N/A |
| Sun et al. (2019) | • Subjects who had not lived at an altitude lower than 1000 m. |
Abbreviations: BP = blood pressure; COPD = chronic obstructive pulmonary disease; MMSE = Mini-Mental State Examination; N/A = not available; NYHA III–IV FC = New York Heart Association Functional Class III–IV.
Fig. 2Forest plot depicting the standardized mean difference effect sizes (hypoxia vs. normoxia) and 95%CI for Aim 1. Ando et al. (2013): a = response time in Go/No-Go task; b = response accuracy in Go/No-Go task. Schega et al. (2013): a = SKL in d2 test; b = GZ in d2 test; c = Zahlen Verbindungs test. Komiyama et al. (2015): a = accuracy in spatial delayed response; b = response accuracy in Go/No-Go task. Seo et al. (2015): a = response time in Go/No-Go task; b = response accuracy in Go/No-Go task; c = response time in running memory continuous performance task; d = response accuracy in running memory continuous performance task; e = total score in running memory continuous performance task. Dobashi et al. (2016): a = Reverse-Stroop control task; b = Reverse-Stroop interference task; c = Stroop control task; d = Stroop interference task. Schega et al. (2016): a = Word-task of the Stroop test; b = Color-task of the Stroop test; c = Word-color-task of the Stroop test. Bayer et al. (2017): a = Dementia detection test; b = Clock-drawing test. Bayer et al. (2017): a = Dementia detection test; b = Clock-drawing test. Komiyama et al. (2017): a = accuracy in spatial delayed response; b = response accuracy on Go trial in the Go/No-Go task; c = response accuracy on No-Go trial in the Go/No-Go task; d = response time in Go/No-Go task. Seo et al. (2017): total score in running memory continuous performance task. Lei et al. (2019): response time in Go/No-Go task. Sun et al. (2019): a = response time in Go/No-Go task; b = response accuracy in Go/No-Go task. CI = confidence interval; diff = difference; Std = standardized.
Fig. 3Forest plot depicting the standardized mean difference effect sizes (exercise vs. no exercise) and 95%CI for Aim 2. Ando et al. (2013): a = response time in Go/No-Go task; b = response accuracy in Go/No-Go task. Schega et al. (2013): a = SKL in d2 test; b = GZ in d2 test; c = Zahlen Verbindungs test. Komiyama et al. (2015): a = accuracy in spatial delayed response; b = response accuracy in Go/No-Go task. Seo et al. (2015): a = response time in running memory continuous performance; b = response time in running memory continuous performance; c = total score in running memory continuous performance task; d = Total score in running memory continuous performance task. Dobashi et al. (2016): a = Reverse-Stroop control task; b = Reverse-Stroop interference task; c = Stroop control task; d = Stroop interference task. Schega et al. (2016): a = Word-task of the Stroop test; b = Color-task of the Stroop test; c = Word-color-task of the Stroop test. Bayer et al. (2017): a = Dementia detection test; b = Clock-drawing test. Bayer et al. (2017): a = Dementia detection test; b = Clock-drawing test. Komiyama et al. (2017): a = accuracy in spatial delayed response; b = response accuracy on Go trial in the Go/No-Go task; c = response accuracy on No-Go trial in the Go/No-Go task. Seo et al. (2017): total score in running memory continuous performance task. Morrison et al. (2019): accuracy in one card learning task. Sun et al. (2019): a = response time in Go/No-Go task; b = response accuracy in Go/No-Go task. CI = confidence interval; diff = difference; Std = standardized.
Effect sizes by moderator variables in meta-analysis of variance for Aim 1.
| Category | Effect size | SMD | 95%CI | |
|---|---|---|---|---|
| 15.22 | ||||
| Male | 17 | –0.30 | –0.48 to –0.11 | |
| Female | 2 | 0.39 | 0.09 to 0.69 | |
| Mixed | 12 | 0.02 | –0.19 to 0.22 | |
| 2.01 | ||||
| Young Adults | 21 | –0.20 | –0.39 to 0.00 | |
| Older Adults | 10 | 0.01 | –0.20 to 0.23 | |
| 10.33 | ||||
| Information processing | 7 | 0.27 | 0.00 to 0.53 | |
| Attention | 2 | –0.40 | –0.88 to 0.09 | |
| Executive function | 12 | –0.18 | –0.39 to 0.02 | |
| Memory | 10 | –0.26 | –0.55 to 0.04 | |
| 2.38 | ||||
| RCT | 12 | 0.02 | –0.19 to 0.22 | |
| NRS | 19 | –0.21 | –0.41 to −0.01 |
p < 0.05; ** p < 0.01.
Abbreviations: CI = confidence interval; NRS = non-randomized controlled study; RCT = randomized controlled trial; SMD = standardized mean difference; Qb = Cochran's Q statistics.
Fig. 4Effect sizes by moderator variables in meta-regression for Aim 1. (A) Regression of hypoxia duration on SMD; (B) Regression of hypoxia level (FIO2) on SMD; (C) Regression of hypoxia dose on SMD. FIO2 = fraction of inspired oxygen; SMD = standardized mean difference.
Effect sizes by moderator variables in meta-analysis of variance for Aim 2.
| Category | Effect size | SMD | 95%CI | |
|---|---|---|---|---|
| 2.96 | ||||
| Male | 16 | 0.18 | –0.03 to 0.38 | |
| Female | 1 | 0.52 | –0.03 to 1.07 | |
| Mixed | 12 | 0.42 | 0.19 to 0.65 | |
| 6.30 | ||||
| Young adults | 19 | 0.16 | –0.04 to 0.36 | |
| Older adults | 10 | 0.51 | 0.32 to 0.69 | |
| 9.34 | ||||
| Information processing | 7 | 0.26 | 0.03 to 0.49 | |
| Attention | 2 | 0.78 | 0.39 to 1.17 | |
| Executive function | 8 | 0.07 | –0.19 to 0.33 | |
| Memory | 12 | 0.38 | 0.12 to 0.64 | |
| 1.98 | ||||
| RCT | 12 | 0.42 | 0.19 to 0.65 | |
| NRS | 17 | 0.20 | 0.00 to 0.40 | |
| 17.12 | ||||
| Cycle ergometer | 21 | 0.23 | 0.06 to 0.40 | |
| Full-body strength-endurance program | 3 | 0.70 | 0.39 to 1.01 | |
| Multimodal training program | 4 | 0.50 | 0.14 to 0.85 | |
| Repeated sprint running | 1 | –0.71 | –1.38 to −0.04 | |
| 3.98 | ||||
| Moderate | 26 | 0.36 | 0.22 to 0.50 | |
| High | 3 | –0.41 | –1.16 to 0.34 | |
| 1.43 | ||||
| During hypoxia | 8 | 0.45 | 0.13 to 0.78 | |
| Both before and during hypoxia | 21 | 0.23 | 0.06 to 0.40 | |
| 6.30 | ||||
| Acute exercise | 19 | 0.16 | –0.04 to 0.36 | |
| Chronic exercise | 10 | 0.51 | 0.32 to 0.69 |
p < 0.05; ** p < 0.01.
Abbreviations: CI = confidence interval; NRS = non-randomized controlled study; RCT = randomized controlled trial; SMD = standardized mean difference; Qb = Cochran Q statistics.
Fig. 5Effect sizes by moderator variables in meta-regression for Aim 2. (A) Regression of exercise duration on SMD; (B) Regression of hypoxia duration on SMD; (C) Regression of hypoxia level (FIO2) on SMD; (D) Regression of hypoxia dose on SMD. FIO2 = fraction of inspired oxygen; SMD = standardized mean difference.